Passage Bio Yönetim

Yönetim kriter kontrolleri 1/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Will Chou

İcra Kurulu Başkanı

US$1.4m

Toplam tazminat

CEO maaş yüzdesi41.4%
CEO görev süresi2.1yrs
CEO sahipliğin/a
Yönetim ortalama görev süresi1.3yrs
Yönetim Kurulu ortalama görev süresi3.6yrs

Son yönetim güncellemeleri

Recent updates

Is Passage Bio (NASDAQ:PASG) In A Good Position To Deliver On Growth Plans?

Sep 24
Is Passage Bio (NASDAQ:PASG) In A Good Position To Deliver On Growth Plans?

Is Passage Bio (NASDAQ:PASG) In A Good Position To Deliver On Growth Plans?

Jun 11
Is Passage Bio (NASDAQ:PASG) In A Good Position To Deliver On Growth Plans?

We're Keeping An Eye On Passage Bio's (NASDAQ:PASG) Cash Burn Rate

Feb 27
We're Keeping An Eye On Passage Bio's (NASDAQ:PASG) Cash Burn Rate

Is Passage Bio (NASDAQ:PASG) In A Good Position To Deliver On Growth Plans?

Nov 13
Is Passage Bio (NASDAQ:PASG) In A Good Position To Deliver On Growth Plans?

We Think Passage Bio (NASDAQ:PASG) Needs To Drive Business Growth Carefully

Jun 23
We Think Passage Bio (NASDAQ:PASG) Needs To Drive Business Growth Carefully

Is Passage Bio (NASDAQ:PASG) In A Good Position To Deliver On Growth Plans?

Nov 13
Is Passage Bio (NASDAQ:PASG) In A Good Position To Deliver On Growth Plans?

Passage appoints William Chou CEO

Oct 10

Passage Bio GAAP EPS of -$0.73 beats by $0.09

Aug 04

We're A Little Worried About Passage Bio's (NASDAQ:PASG) Cash Burn Rate

Jun 03
We're A Little Worried About Passage Bio's (NASDAQ:PASG) Cash Burn Rate

Passage Bio: Worth Keeping An Eye On

Apr 11

Will Passage Bio (NASDAQ:PASG) Spend Its Cash Wisely?

Dec 15
Will Passage Bio (NASDAQ:PASG) Spend Its Cash Wisely?

Passage Bio (NASDAQ:PASG) Is In A Good Position To Deliver On Growth Plans

Aug 19
Passage Bio (NASDAQ:PASG) Is In A Good Position To Deliver On Growth Plans

Passage Bio: Price Reduced, But Without Data, Does Not Look Convincing

Jun 06

Passage Bio partners with InformedDNA to offer counseling, testing for early dementia

May 03

We're Hopeful That Passage Bio (NASDAQ:PASG) Will Use Its Cash Wisely

Mar 08
We're Hopeful That Passage Bio (NASDAQ:PASG) Will Use Its Cash Wisely

Do Institutions Own Passage Bio, Inc. (NASDAQ:PASG) Shares?

Feb 01
Do Institutions Own Passage Bio, Inc. (NASDAQ:PASG) Shares?

Passage Bio on go with PBGM01 gene therapy trial in the U.S.

Jan 04

Need To Know: Passage Bio, Inc. (NASDAQ:PASG) Insiders Have Been Buying Shares

Dec 28
Need To Know: Passage Bio, Inc. (NASDAQ:PASG) Insiders Have Been Buying Shares

U.K. authorizes Passage Bio's PBGM01 trial

Dec 10

Passage Bio (PASG) Investor Presentation - Slideshow

Nov 16

Passage Bio EPS beats by $0.13

Nov 10

Passage Bio’s PBKR03 nabs Orphan drug tag and accelerated review status for Krabbe disease

Oct 28

CEO Tazminat Analizi

Will Chou'un ücretlendirmesi Passage Bio'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Sep 30 2024n/an/a

-US$69m

Jun 30 2024n/an/a

-US$77m

Mar 31 2024n/an/a

-US$84m

Dec 31 2023US$1mUS$599k

-US$102m

Sep 30 2023n/an/a

-US$112m

Jun 30 2023n/an/a

-US$112m

Mar 31 2023n/an/a

-US$128m

Dec 31 2022US$1mUS$112k

-US$136m

Tazminat ve Piyasa: Will 'nin toplam tazminatı ($USD 1.45M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 646.00K ).

Tazminat ve Kazançlar: Will şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.


CEO

Will Chou (51 yo)

2.1yrs

Görev süresi

US$1,448,546

Tazminat

Dr. William Chou, MD, also known as Will, has been the Chief Executive Officer and Director of Passage Bio, Inc. from October 10, 2022 and serves as its President. Dr. Chou is an accomplished executive wit...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
William Chou
President2.1yrsUS$1.45mVeri yok
Edgar Cale
General Counsel & Company Secretary5.2yrsUS$804.69k0.080%
$ 30.7k
James Wilson
Co-Founder & Chief Scientific Advisorno dataVeri yokVeri yok
Kathleen Borthwick
Senior VP1.3yrsVeri yok0.046%
$ 17.7k
Stuart Henderson
Senior Vice President of Corporate Development & Investor Relations3.8yrsVeri yokVeri yok
Eden Fucci
Senior Vice President of Technical Operations1.3yrsVeri yokVeri yok
Sue Browne
Senior Vice President of Research & Developmentless than a yearVeri yokVeri yok
Karl Whitney
Senior Vice President of Global Regulatory Affairsless than a yearVeri yokVeri yok

1.3yrs

Ortalama Görev Süresi

55.5yo

Ortalama Yaş

Deneyimli Yönetim: PASG 'un yönetim ekibi deneyimli olarak kabul edilmiyor ( 1.3 yıl), bu da yeni bir ekibin varlığını gösteriyor.


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
William Chou
President2.1yrsUS$1.45mVeri yok
Thomas Kassberg
Directorless than a yearVeri yokVeri yok
Maxine Gowen
Independent Chairwoman of the Board3.8yrsUS$101.34k0%
$ 0
Saqib Islam
Independent Director5.7yrsUS$65.84k0.0081%
$ 3.1k
Athena Countouriotis
Independent Director4.8yrsUS$69.97k0.031%
$ 11.7k
Sandip Kapadia
Independent Director4.9yrsUS$73.34k0%
$ 0
Derrell Porter
Independent Director3.5yrsUS$69.30k0%
$ 0
Dolan Sondhi
Independent Director1.3yrsUS$49.90k0%
$ 0

3.6yrs

Ortalama Görev Süresi

53.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: PASG 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.6 yıldır).